In summary, this study identified 114 BPA-related pathogenic targets in ccRCC and highlighted 23 key targets—including AKT1, ESR1, PTGS2, and PPARG—that may play pivotal roles in BPA-induced renal carcinogenicity. The gene discussed is PTGS2; the disease is nonpapillary renal cell carcinoma.